Logo image of IMAX

IMAX CORP (IMAX) Stock Fundamental Analysis

USA - NYSE:IMAX - CA45245E1097 - Common Stock

33.59 USD
+0.03 (+0.09%)
Last: 11/6/2025, 1:50:04 PM
Fundamental Rating

5

Overall IMAX gets a fundamental rating of 5 out of 10. We evaluated IMAX against 79 industry peers in the Entertainment industry. Both the profitability and the financial health of IMAX get a neutral evaluation. Nothing too spectacular is happening here. IMAX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

IMAX had positive earnings in the past year.
In the past year IMAX had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: IMAX reported negative net income in multiple years.
Of the past 5 years IMAX 4 years had a positive operating cash flow.
IMAX Yearly Net Income VS EBIT VS OCF VS FCFIMAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of 4.45%, IMAX is in the better half of the industry, outperforming 75.95% of the companies in the same industry.
The Return On Equity of IMAX (11.31%) is better than 78.48% of its industry peers.
With a decent Return On Invested Capital value of 7.73%, IMAX is doing good in the industry, outperforming 79.75% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for IMAX is significantly below the industry average of 9.25%.
The 3 year average ROIC (4.23%) for IMAX is below the current ROIC(7.73%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.45%
ROE 11.31%
ROIC 7.73%
ROA(3y)1.16%
ROA(5y)-2.69%
ROE(3y)3.11%
ROE(5y)-6.85%
ROIC(3y)4.23%
ROIC(5y)N/A
IMAX Yearly ROA, ROE, ROICIMAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

IMAX's Profit Margin of 10.47% is amongst the best of the industry. IMAX outperforms 83.54% of its industry peers.
In the last couple of years the Profit Margin of IMAX has declined.
IMAX's Operating Margin of 19.91% is amongst the best of the industry. IMAX outperforms 92.41% of its industry peers.
In the last couple of years the Operating Margin of IMAX has declined.
Looking at the Gross Margin, with a value of 58.89%, IMAX is in the better half of the industry, outperforming 67.09% of the companies in the same industry.
IMAX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.91%
PM (TTM) 10.47%
GM 58.89%
OM growth 3Y86.93%
OM growth 5Y-7.23%
PM growth 3YN/A
PM growth 5Y-8.99%
GM growth 3Y0.8%
GM growth 5Y-0.05%
IMAX Yearly Profit, Operating, Gross MarginsIMAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), IMAX is creating some value.
Compared to 1 year ago, IMAX has less shares outstanding
The number of shares outstanding for IMAX has been reduced compared to 5 years ago.
The debt/assets ratio for IMAX is higher compared to a year ago.
IMAX Yearly Shares OutstandingIMAX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
IMAX Yearly Total Debt VS Total AssetsIMAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 2.57 indicates that IMAX is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.57, IMAX is doing good in the industry, outperforming 70.89% of the companies in the same industry.
The Debt to FCF ratio of IMAX is 2.85, which is a good value as it means it would take IMAX, 2.85 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 2.85, IMAX is doing good in the industry, outperforming 77.22% of the companies in the same industry.
IMAX has a Debt/Equity ratio of 0.74. This is a neutral value indicating IMAX is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.74, IMAX is not doing good in the industry: 62.03% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 2.85
Altman-Z 2.57
ROIC/WACC1.09
WACC7.1%
IMAX Yearly LT Debt VS Equity VS FCFIMAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

IMAX has a Current Ratio of 2.47. This indicates that IMAX is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.47, IMAX is doing good in the industry, outperforming 75.95% of the companies in the same industry.
A Quick Ratio of 2.12 indicates that IMAX has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.12, IMAX is doing good in the industry, outperforming 75.95% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.47
Quick Ratio 2.12
IMAX Yearly Current Assets VS Current LiabilitesIMAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

5

3. Growth

3.1 Past

IMAX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.94%, which is quite impressive.
Measured over the past years, IMAX shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.17% on average per year.
Looking at the last year, IMAX shows a quite strong growth in Revenue. The Revenue has grown by 9.30% in the last year.
The Revenue has been decreasing by -2.30% on average over the past years.
EPS 1Y (TTM)32.94%
EPS 3YN/A
EPS 5Y-2.17%
EPS Q2Q%34.29%
Revenue 1Y (TTM)9.3%
Revenue growth 3Y11.38%
Revenue growth 5Y-2.3%
Sales Q2Q%16.62%

3.2 Future

IMAX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.18% yearly.
Based on estimates for the next years, IMAX will show a small growth in Revenue. The Revenue will grow by 7.55% on average per year.
EPS Next Y38.44%
EPS Next 2Y28.99%
EPS Next 3Y20.17%
EPS Next 5Y24.18%
Revenue Next Year12.24%
Revenue Next 2Y9.17%
Revenue Next 3Y7.55%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IMAX Yearly Revenue VS EstimatesIMAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
IMAX Yearly EPS VS EstimatesIMAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

IMAX is valuated quite expensively with a Price/Earnings ratio of 29.73.
Based on the Price/Earnings ratio, IMAX is valued a bit cheaper than the industry average as 77.22% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of IMAX to the average of the S&P500 Index (26.13), we can say IMAX is valued inline with the index average.
With a Price/Forward Earnings ratio of 21.25, IMAX is valued on the expensive side.
Based on the Price/Forward Earnings ratio, IMAX is valued cheaper than 82.28% of the companies in the same industry.
IMAX is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.35, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 29.73
Fwd PE 21.25
IMAX Price Earnings VS Forward Price EarningsIMAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

IMAX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. IMAX is cheaper than 67.09% of the companies in the same industry.
IMAX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. IMAX is cheaper than 84.81% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.01
EV/EBITDA 14.14
IMAX Per share dataIMAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IMAX has a very decent profitability rating, which may justify a higher PE ratio.
IMAX's earnings are expected to grow with 20.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.77
PEG (5Y)N/A
EPS Next 2Y28.99%
EPS Next 3Y20.17%

0

5. Dividend

5.1 Amount

IMAX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

IMAX CORP

NYSE:IMAX (11/6/2025, 1:50:04 PM)

33.59

+0.03 (+0.09%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)10-23 2025-10-23/bmo
Earnings (Next)02-17 2026-02-17
Inst Owners90.65%
Inst Owner Change0.13%
Ins Owners19.38%
Ins Owner Change-0.54%
Market Cap1.81B
Revenue(TTM)377.68M
Net Income(TTM)39.55M
Analysts80
Price Target38.42 (14.38%)
Short Float %13.98%
Short Ratio6.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.48%
Min EPS beat(2)20.24%
Max EPS beat(2)20.72%
EPS beat(4)3
Avg EPS beat(4)11.61%
Min EPS beat(4)-6.42%
Max EPS beat(4)20.72%
EPS beat(8)7
Avg EPS beat(8)65.63%
EPS beat(12)10
Avg EPS beat(12)54.13%
EPS beat(16)11
Avg EPS beat(16)15.31%
Revenue beat(2)0
Avg Revenue beat(2)-1.01%
Min Revenue beat(2)-1.46%
Max Revenue beat(2)-0.56%
Revenue beat(4)1
Avg Revenue beat(4)-3.09%
Min Revenue beat(4)-11.37%
Max Revenue beat(4)1.04%
Revenue beat(8)2
Avg Revenue beat(8)-0.56%
Revenue beat(12)6
Avg Revenue beat(12)1.35%
Revenue beat(16)7
Avg Revenue beat(16)2.11%
PT rev (1m)11.38%
PT rev (3m)18.72%
EPS NQ rev (1m)-9.48%
EPS NQ rev (3m)-9.48%
EPS NY rev (1m)4.11%
EPS NY rev (3m)12.79%
Revenue NQ rev (1m)-4.6%
Revenue NQ rev (3m)-4.72%
Revenue NY rev (1m)0.66%
Revenue NY rev (3m)0.77%
Valuation
Industry RankSector Rank
PE 29.73
Fwd PE 21.25
P/S 4.78
P/FCF 20.01
P/OCF 16.55
P/B 5.17
P/tB 7.19
EV/EBITDA 14.14
EPS(TTM)1.13
EY3.36%
EPS(NY)1.58
Fwd EY4.71%
FCF(TTM)1.68
FCFY5%
OCF(TTM)2.03
OCFY6.04%
SpS7.02
BVpS6.5
TBVpS4.67
PEG (NY)0.77
PEG (5Y)N/A
Graham Number12.85
Profitability
Industry RankSector Rank
ROA 4.45%
ROE 11.31%
ROCE 9.75%
ROIC 7.73%
ROICexc 9.49%
ROICexgc 14.13%
OM 19.91%
PM (TTM) 10.47%
GM 58.89%
FCFM 23.9%
ROA(3y)1.16%
ROA(5y)-2.69%
ROE(3y)3.11%
ROE(5y)-6.85%
ROIC(3y)4.23%
ROIC(5y)N/A
ROICexc(3y)4.84%
ROICexc(5y)N/A
ROICexgc(3y)7.01%
ROICexgc(5y)N/A
ROCE(3y)5.33%
ROCE(5y)N/A
ROICexgc growth 3Y113.18%
ROICexgc growth 5Y-5.75%
ROICexc growth 3Y103.14%
ROICexc growth 5Y-8.28%
OM growth 3Y86.93%
OM growth 5Y-7.23%
PM growth 3YN/A
PM growth 5Y-8.99%
GM growth 3Y0.8%
GM growth 5Y-0.05%
F-Score8
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 2.85
Debt/EBITDA 1.9
Cap/Depr 31.29%
Cap/Sales 5.01%
Interest Coverage 250
Cash Conversion 80.47%
Profit Quality 228.24%
Current Ratio 2.47
Quick Ratio 2.12
Altman-Z 2.57
F-Score8
WACC7.1%
ROIC/WACC1.09
Cap/Depr(3y)25.16%
Cap/Depr(5y)18.94%
Cap/Sales(3y)4.33%
Cap/Sales(5y)3.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.94%
EPS 3YN/A
EPS 5Y-2.17%
EPS Q2Q%34.29%
EPS Next Y38.44%
EPS Next 2Y28.99%
EPS Next 3Y20.17%
EPS Next 5Y24.18%
Revenue 1Y (TTM)9.3%
Revenue growth 3Y11.38%
Revenue growth 5Y-2.3%
Sales Q2Q%16.62%
Revenue Next Year12.24%
Revenue Next 2Y9.17%
Revenue Next 3Y7.55%
Revenue Next 5YN/A
EBIT growth 1Y94.17%
EBIT growth 3Y108.21%
EBIT growth 5Y-9.36%
EBIT Next Year247.81%
EBIT Next 3Y56.91%
EBIT Next 5Y33.94%
FCF growth 1Y52.72%
FCF growth 3YN/A
FCF growth 5Y-7.57%
OCF growth 1Y52.91%
OCF growth 3Y126.45%
OCF growth 5Y-4.76%

IMAX CORP / IMAX FAQ

What is the fundamental rating for IMAX stock?

ChartMill assigns a fundamental rating of 5 / 10 to IMAX.


What is the valuation status for IMAX stock?

ChartMill assigns a valuation rating of 6 / 10 to IMAX CORP (IMAX). This can be considered as Fairly Valued.


What is the profitability of IMAX stock?

IMAX CORP (IMAX) has a profitability rating of 6 / 10.


What is the valuation of IMAX CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for IMAX CORP (IMAX) is 29.73 and the Price/Book (PB) ratio is 5.17.


What is the expected EPS growth for IMAX CORP (IMAX) stock?

The Earnings per Share (EPS) of IMAX CORP (IMAX) is expected to grow by 38.44% in the next year.